Regeneron builds on Together for CHANGE™ initiative with five-year, $5 million commitment to fuel the STEM talent pipeline in Nashville, TN
18 Outubro 2023 - 10:30AM
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced a
five-year, $5 million strategic investment to bolster Nashville,
Tennessee’s science, technology, engineering and mathematics (STEM)
ecosystem through high-quality, equitable engagement programs for
students and science teachers. Regeneron’s goal is to engage and
inspire the next generation of scientific leaders and innovators to
help address some of humanity’s most challenging existential
threats.
Regeneron will collaborate with the Nashville STEM ecosystem to
support existing programs and adapt initiatives that have proven
successful in its local New York high school community, as
evidenced by student success in the premier high school science
competitions. Collaborators will include a number of schools,
non-governmental organizations, businesses and universities,
including Vanderbilt University’s Collaborative for Science
Education and Outreach, Tennessee STEM Innovation
Network, Middle Tennessee Science & Engineering Fair, Project
Lead The Way, Yonkers Partners In Education, STEM Leadership Center
and Society for Science. With its partners, Regeneron will assess
Nashville’s current landscape and continuously evolve and adapt its
programs for maximum impact on the region's education system.
“I owe my scientific passion and career to programs that got me
started when I was in high school – including science research
programs and the challenge of the Science Talent Search – which
together changed my life and inspired me to pursue science to help
cure disease,” said George D. Yancopoulos, M.D., Ph.D.,
Co-Founder, Co-Chair, President and Chief Scientific Officer of
Regeneron. “Among the many STEM programs we support, the ones
created in our own backyard of New York over the past decade have
proven successful, in part reflected by the success of our local
students at the premier high school science competitions. We’re
excited to support Nashville in similar ways, and coupled with
Together for CHANGE, we hope to unlock and nurture the potential of
students, to help promote the next generation of scientific leaders
and innovators.”
Regeneron has long-committed to bolstering STEM education at
various scales, aiming to encourage more students to pursue careers
in these fields and nurture future innovators. The company’s
substantial philanthropic commitments include a 10-year, $100
million commitment as the lead sponsor of the Regeneron Science
Talent Search (STS), the nation’s oldest and most prestigious
pre-college science and mathematics competition, and a five-year,
$24 million commitment as lead sponsor of the Regeneron
International Science and Engineering Fair (ISEF), the world’s
largest high school STEM competition.
In Regeneron’s home state of New York, Regeneron has focused on
fostering partnerships with organizations to help strengthen local
STEM education and build programs in the area. These initiatives
have proven successful in helping students excel in STEM fields and
consistently secure placements at these premier competitions. The
learnings from this work will be reflected in Regeneron’s
commitment to Nashville and evaluated for replication in other
cities in the future.
Earlier today, the Together for CHANGE™ (“Together for
Changing Healthcare for People of African-Ancestry through an
InterNational Genomics & Equity”) initiative was launched in
Nashville to address health disparities and promote health in Black
communities across the country. A key component of this initiative
is to empower educational change by improving the STEM pipeline for
Black students. Together for CHANGE is an alliance established by
Nashville-based historically Black medical school, Meharry Medical
College, and includes the Diaspora Human Genomics Institute and
several biopharmaceutical companies, including Regeneron.
Supporting Nashville’s STEM Ecosystem
“At Regeneron, our commitment to STEM education is a holistic
endeavor focused on strengthening the entire ecosystem,” said
Christina Chan, Senior Vice President, Corporate Affairs at
Regeneron. “By supporting Nashville’s science research programs and
applying learnings from the programs we have built in New York to
Nashville’s unique STEM environment, we hope to enable more
students and teachers to engage with and excel in these fields, and
to illuminate the many exciting pathways to STEM careers.”
Regeneron’s efforts in Nashville will work to grant teachers
research fellowships and professional development opportunities
annually, increase student success rates for awards, scholarships,
and STEM-centric higher education opportunities, grow the volume of
student research projects showcased at science competitions and
boost the retention rate of science research teachers.
About Regeneron
Regeneron (NASDAQ: REGN) is a leading biotechnology company that
invents life-transforming medicines for people with serious
diseases. Founded and led for 35 years by physician-scientists, our
unique ability to repeatedly and consistently translate science
into medicine has led to numerous FDA-approved treatments and
product candidates in development, almost all of which were
homegrown in our laboratories. Regeneron’s medicines and pipeline
are designed to help patients with eye diseases, allergic and
inflammatory diseases, cancer, cardiovascular and metabolic
diseases, hematologic conditions, infectious diseases and rare
diseases.
Regeneron believes that operating as a good corporate citizen is
crucial to delivering on our mission. We approach corporate
responsibility with three goals in mind: to improve the lives of
people with serious diseases, to foster a culture of
integrity and excellence and to build sustainable
communities. Regeneron is proud to be included on the Dow Jones
Sustainability World Index and the Civic 50 list of the most
“community-minded” companies in the United States. Throughout
the year, Regeneron empowers and supports employees to give back
through our volunteering, pro-bono and matching gift programs. Our
most significant philanthropic commitments are in the area of
science education, including the Regeneron Science Talent
Search and Regeneron International Science and
Engineering Fair.
For additional information about Regeneron, please
visit www.regeneron.com or follow Regeneron
on LinkedIn.
Media Contacts:
Joseph Brown,
Regeneron386-283-1323Joseph.Brown2@regeneron.com
Regeneron Pharmaceuticals (NASDAQ:REGN)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Regeneron Pharmaceuticals (NASDAQ:REGN)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024